NCT00129402
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)
See it on ClinicalTrials.gov ↗248 people
42.7%
57.3%
106 womenmiddle line = equal numbers142 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2007-06
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 10 Years – 17 Years
- Average age
- mean 14.2 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 17 Years.”
Study titles and rules are shown in their original English.